Source: Annual Congress 2006 - COPD – inflammation/miscellaneous
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Magula, M. Culagová, I. Libáková, J. Plutinský, S. Petrícek (Nitra, Slovakia). Is there a relationship between severity of COPD and C-reactive protein (CRP) levels?. Eur Respir J 2006; 28: Suppl. 50, 327

Member's Comments

No comment yet.

Related content which might interest you: Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. Source: International Congress 2017 – COPD biomarkers Year: 2017 The association of C-reactive protein, serum amyloid-A and fibrinogen with prevalent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 506s Year: 2001 Are C-reactive protein levels associated with bacteria in COPD exacerbations? Source: Eur Respir J 2015; 45: 1515-1516 Year: 2015 Are C-reactive protein levels associated with bacteria in COPD exacerbations? Source: Eur Respir J 2015; 45: 1514-1515 Year: 2015 C-reactive protein serum levels, genotypes and the risk of COPD. The Rotterdam study Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD Year: 2008 COPD, asthma and C-reactive protein Source: Eur Respir J 2006; 27: 874-876 Year: 2006 C-reactive protein (CRP) at admission: is it really usefull in COVID-19 pneumonia? Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 C-reactive protein (CRP) as a risk marker in COPD patients with ischaemic heart disease Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 The relationship between the serum YKL-40 level and severity of asthma Source: Annual Congress 2012 - Asthma management Year: 2012 Diagnostic accuracy of lipopolysaccharide-binding protein (LBP), fibrinogen and C-reactive protein (CRP) in differentiating pneumonia from acute bronchitis in primary care Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care Year: 2008 Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Source: Eur Respir J 2008; 32: 1451-1457 Year: 2008 C-reactive protein in pulmonary tuberculosis-correlation with extent and severity of the disease Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 PP302 – The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension Source: ERS Lung Science Conference 2021 Year: 2021 Procalcitonin and C-reactive protein levels in infective attacks of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 337s Year: 2003 High-sensitive C-reactive protein is associated with reduced lung function in young adults Source: Eur Respir J 2009; 33: 382-388 Year: 2009 The study on the association of serum C-reactive protein level with the risk of lung cancer Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009 High sensitivity C-reactive protein in asthma Source: Eur Respir J 2006; 27: 908-912 Year: 2006 Prognosis value of initial C-reactive protein (CRP) assay in patients with community acquired pneumonia Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008